Infinity Announces Small Molecule Alliance With Johnson & Johnson Pharmaceutical Research & Development
Highlights Technology Platform Benefits of Industrialized Scale and Broad Therapeutic Utility
LabLogic’s New STacy System for Tracking Isotopes and Samples
STacy is a new system from LabLogic for the real-time stock control and tracking of radioisotope compounds and samples of all kinds in drug metabolism studies.
CSS Informatics Offers First Commercially Available Software Designed Specifically for Converting Oracle® Clinical Data to New CDISC SDTM 3.1 Format
PPD, Inc. today announced CSS Informatics, the clinical and safety data management consulting services and proprietary e-technologies division of PPD, has released OC2SDS, the first standardized and validated software that converts Oracle® Clinical data to submission-ready data sets that follow standards recently adopted by the U.S. Food and Drug Administration (FDA). PPD is a partner member of the Oracle PartnerNetwork.
SEQUENOM Records Strong Fourth Quarter MassARRAY(R) System Placements
Nine MassARRAY Systems Placed: Indicates Increased Acceptance in Expanding Market
Adventium Enterprises Receives Grant from NASA
Four-Year Research Program Will Improve Autonomy of Space-Based Software
SAIC Teams with Software Control International on Department of Energy IT Contract
Science Applications International Corporation (SAIC) today announced a teaming arrangement with Software Control International (SCI) to compete for the information technology (IT) support services contract at the U.S. Department of Energy’s (DOE) Oak Ridge facilities.
Agilent Technologies acquires Computational Biology Corp., pioneer in gene regulation analysis
Agilent gains exclusive access to intellectual property for ChIP-on-chip, plans collaborative research center in Cambridge, Mass.
Agilent Technologies expands microarray platform to address new array-based genomics, disease research applications
Agilent Technologies Inc. today announced plans to expand its microarray platform to include new applications in array-based genomics research. These applications hold promise for disease research, drug discovery and drug development.
Manakoa To Launch KnowledgeBase-TM-, Internet-Based Regulatory Compliance Tool
Manakoa Services Corporation, a pioneer in risk management and regulatory compliance solutions, today revealed plans for the Feb. 2005 launch of the Manakoa KnowledgeBase(TM), a subscription based portal for regulatory compliance information, full legislative reviews, examiner guidelines, roadmaps, policy templates, security feeds, and extensive cross references
MediRegs Acquires Compliance Software from Precyse Solutions
MediRegs announced today that it has acquired the compliance assessment and management tool (CAMT) software assets of Precyse Solutions.
Arch Chemicals Named to Information Week 500 List for Innovative Use of Information Technology
Arch Chemicals, Inc. announced that it was named to CMP Media LLC's Information Week 500, a prestigious listing of the most innovative and productive users of information technology (IT) in the United States. Arch ranked sixth among the 15 American chemical companies recognized for IT innovation in 2004.
Air Products and Chemicals Selects Lighthammer for Pipeline Operations; Performance Management Application Integrates Plant Operations in West Gulf Coast
Lighthammer, the leading provider of Manufacturing Intelligence and Collaborative Manufacturing applications, today announced that Air Products and Chemicals, Inc. has successfully deployed Lighthammer's Collaborative Manufacturing Suite (CMS) as the software platform for optimizing Air Products' West Gulf Coast pipeline operations.
DiaSys Corporation Signs Agreement in Principle to Acquire Biocheck, Inc., and EverNew Biotech Inc.; Acquisitions Expected To Dramatically Increase Growth
DiaSys Corporation a global diagnostics products company, announced today that it has executed a letter of intent to acquire all of the outstanding capital stock of Biocheck, Inc. and EverNew Biotech, Inc.,
PharmaFrontiers Expands Its Core Stem Cell Technology License With University Of Chicago
Cell therapy developer PharmaFrontiers Corp. has expanded its intellectual property position underlying its stem cell technology by entering into an Amended and Restated License Agreement with the University of Chicago. This license relates to stem cell technology discovered at The Department of Energy's Office of Science Laboratory, Argonne National Lab. The initial Argonne research was funded by the National Institutes of Health (NIH).
Invitrogen Efficiently Handles Complex Scientific Inquiries Across All Customer Channels With RightNow Technologies
Biotech Equipment Leader Ensures Speed and Accuracy of Replies, While Reducing Call Volume and Costs
Infinity Announces Small Molecule Collaboration With Novartis
Unique Agreement to Jointly Design Novel Compounds for Independent Use
Scientific Software Releases New Proportional Voltage Program for EZChrom Elite™
Scientific Software, Inc. (SSI), a world leader in providing software solutions to the scientific community, announced today the release of a new optional software program to extend the versatility of EZChrom Elite in the laboratory – a software option that performs calculations based on proportionate voltage response.
ObjectSoft Corp. Raises Capital; Invests in Nanotechnology Company
ObjectSoft Corp. today announced that it has received investments totaling $250,000. In addition, it announced that it has invested the funds in a new Nanotechnology venture in partnership with Terra Solar Development Corp.
RAE Systems Adds European ATEX Certification to Entry RAE; Certification Follows Launch of AutoRAE, EntryRAE’s Automated Calibration System
RAE Systems Inc., a leading global developer and manufacturer of rapidly-deployable, multi-sensor chemical and radiation detection monitors and networks for homeland security and industrial applications, today announced that it has received European ATEX certification for EntryRAE, the personal gas monitor for OSHA compliant, hazardous confined space entry (CSE) work.
Imalux Corporation Receives Final FDA Clearance to Market the Niris Imaging System
Imalux Corporation, a medical device company and developer of the Niris(TM) Imaging System based on Optical Coherence Tomography ("OCT") technology, today announced that the Niris System recently received market clearance from the U.S. Food & Drug Administration (FDA). Imalux will begin intensive, broad-based marketing and sales efforts for the system in the first quarter of 2005.
